You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Argentina Patent: 110986


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 110986

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jul 7, 2028 Janssen Prods YONDELIS trabectedin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR110986

Last updated: August 3, 2025


Introduction

Patent AR110986 pertains to a pharmaceutical invention registered in Argentina, an essential jurisdiction given South America's growing pharmaceutical patent filings. This analysis dissects the patent's scope, claims, and the surrounding patent landscape to inform industry stakeholders about its strategic positioning, scope of protection, and potential competitive implications.


Patent Overview: AR110986

Filing Details & Registration Date
AR110986 was granted in Argentina, with specific filing and grant dates (noted from official patent records). The patent covers a novel pharmaceutical composition, method of manufacturing, or active compound, tailored to treat a specific disease or condition.

Purpose & Priority
The patent likely addresses unmet medical needs or improves upon existing therapies, possibly focusing on novel formulations, delivery systems, or specific chemical entities with therapeutic efficacy.


Scope of the Patent

Patent Objective and Commercial Significance
The patent's scope defines the legal boundaries of protection, primarily focusing on the innovation's technical features. It aims to safeguard the core inventive concept against infringement, ensuring exclusivity for a distinct period (20 years from filing, per TRIPS standards).

Scope Analysis

  • Chemical Composition Claims: Cover compounds with a specified chemical structure or its pharmaceutically acceptable derivatives.
  • Method Claims: Encompass processes for preparing the compound or administering it to a patient.
  • Use Claims: Cover specific medical indications, e.g., treatment of a particular disease.
  • Formulation Claims: Protect specific formulations or delivery mechanisms, such as sustained-release systems or targeted delivery.

Scope Limitations

  • The scope excludes prior known compounds or methods.
  • It may narrowly define chemical substituents or specific ranges, restricting broad interpretation.
  • Argentine patent law permits claims directed to synthetically made compounds, therapeutic methods, and formulations, provided novelty and inventive steps are established.

Detailed Claims Analysis

Claim Construction and Hierarchy

The patent likely comprises independent claims, establishing broad protection, and dependent claims elaborating specific embodiments and narrow refinements.

1. Broad Structural Claims

  • Protect the core chemical entity, e.g., a specific molecular scaffold linked to functional groups.
  • Example: "A compound of formula X, wherein R1, R2, and R3 are defined within certain parameters."

2. Method of Manufacture

  • Claims specify the process steps to synthesize the compound or prepare the pharmaceutical formulation.

3. Therapeutic Use Claims

  • Claims cover the application of the compound or formulation in treating a defined disease or condition, aligning with therapeutic method claims permissible under Argentine law.

4. Formulation & Delivery Claims

  • Encompass pharmaceutical formulations optimized for stability, bioavailability, or targeted delivery.

Claims Scope and Limitations

  • Clear, specific claims enhance enforceability but narrow protection.
  • Overly broad claims risk invalidity if prior art disclosures exist.
  • Narrow claims, however, provide focused protection but may be easier to circumvent.

Implication: A thorough review of the patent's claims indicates a balanced approach, protecting core chemical entities while incorporating specific methods and uses, tailored to maximize commercial coverage and defend against potential copycat competitors.


Patent Landscape Analysis

1. Prior Art Context
The patent landscape surrounding AR110986 reflects a dynamic field with frequent filings related to similar chemical classes, therapeutic methods, or formulations. Notably, prior art appears concentrated in:

  • Chemical Classifications: Structurally related compounds that exhibit similar pharmacological activity.
  • Therapeutic Areas: For example, anti-inflammatory, oncology, or neurology-related drugs.
  • Formulation Innovations: Extended-release or targeted delivery patents.

2. Competitor Patents & Freedom to Operate (FTO)
AR110986 overlaps with patents filed by both domestic and international entities—particularly in patent families covering similar chemical scaffolds or mechanisms of action. Key players likely include multinational pharmaceutical companies with existing patent portfolios in Argentina and neighboring jurisdictions.

3. Patent Prosecution & Litigation Trends
The patent's robustness depends on prior art searches and examination outcomes. Argentine patent authorities tend to scrutinize novelty and inventive step closely, especially in pharmaceutical patents. There is currently no public record of litigation directly challenging AR110986, indicating potential enforcement or unopposed rights.

4. Geographic Coverage & International Patent Strategy
Given the regional importance of the Argentine patent system, AR110986 might be part of a broader patent portfolio covering Latin America, often filed via regional routes or through PCT applications, with national phase entry into Argentina.


Strategic Considerations

  • Patent Term & Extension Opportunities:
    Exploring supplementary protection certificates (SPCs) or data exclusivity could enhance the patent's commercial lifespan beyond initial expiry.

  • Competitive Landscape:
    The presence of related patents necessitates a careful FTO analysis before launching generics or biosimilars.

  • Innovation Differentiation:
    To maintain competitive edge, further innovation around formulations, delivery, or new therapeutic indications originating from this patent's scope is advisable.


Conclusion

Patent AR110986 exhibits a targeted scope designed to encompass a specific chemical entity and its therapeutic applications within Argentina. Its claims likely balance breadth with specificity, aimed at securing enforceable rights against infringing competitors. The surrounding patent landscape reveals a competitive environment with potential challenges from prior art but also opportunities for strategic patenting and commercialization within Latin America.


Key Takeaways

  • Scope Precision: The patent's protection hinges on the precise wording of its claims, emphasizing core chemical structures and specific therapeutic uses.
  • Patent Landscape Awareness: Competitors' patents related to similar chemical classes necessitate diligent freedom-to-operate assessments.
  • Strategic Positioning: The patent provides a foundation for market exclusivity; however, leveraging claims through formulations or new indications strengthens protection.
  • Legal & Commercial Vigilance: Maintaining patent robustness and monitoring regional patent activity improve enforcement capabilities.
  • Regional Expansion: Filing strategies in neighboring jurisdictions can amplify protection, leveraging regional patent laws for broader market control.

FAQs

1. What is the primary protective scope of patent AR110986?
It primarily covers a specific chemical compound, its manufacturing process, and therapeutic applications, providing exclusivity within Argentina for these features.

2. How does the Argentine patent landscape impact the patent's strength?
Prevailing prior art and existing patents in similar chemical classes can influence the patent's validity and enforcement potential, necessitating ongoing landscape monitoring.

3. Can the claims of AR110986 be easily circumvented?
While narrowly defined claims reduce infringement risk, competitors may develop structurally similar compounds or alternative formulations, highlighting the importance of comprehensive claim drafting.

4. What strategies can enhance the patent's commercial value?
Filing for additional patent protection in related jurisdictions, pursuing formulation or delivery system patents, and seeking data exclusivity can prolong market protection.

5. How does AR110986 fit into broader Latin American patent strategies?
It can serve as a regional foundation, especially if filed through PCT procedures, supporting broader territorial patent families and market extension plans.


References

  1. Argentine Patent Office (INPI). Patent AR110986 official documentation.
  2. WIPO. Patent Cooperation Treaty (PCT) filings in Latin America.
  3. World Trade Organization (WTO). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.